{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:01:00Z","timestamp":1791824460671,"version":"4.3.4"},"reference-count":31,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Riboflavin transporter deficiencies (RTDs), involving <jats:italic>SLC52A3<\/jats:italic> and <jats:italic>SLC52A2<\/jats:italic> genes, have recently been related to Brown-Vialetto-Van Laere (BVVL) syndrome, a hereditary paediatric condition associating motor neuropathy (MN) and deafness. BVVL\/RTD has rarely been reported in adult patients, but is probably underdiagnosed due to poor knowledge and lack of awareness of this form of disease among neurologists. In this study, we aimed to investigate the phenotype and prognosis of RTD patients with late-onset MN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively collected clinical, biological and electrophysiological data from all French RTD patients with MN onset after 10 years of age (n=6) and extracted data from 19 other similar RTD patients from the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Adult RTD patients with MN had heterogeneous clinical presentations, potentially mimicking amyotrophic lateral sclerosis or distal hereditary motor neuropathy (56%), multinevritis with cranial nerve involvement (16%), Guillain-Barr\u00e9 syndrome (8%) and mixed motor and sensory neuronopathy syndromes (20%, only in <jats:italic>SLC52A2<\/jats:italic> patients). Deafness was often diagnosed before MN (in 44%), but in some patients, onset began only with MN (16%). The pattern of weakness varied widely, and the classic pontobulbar palsy described in BVVL was not constant. Biochemical tests were often normal. The majority of patients improved under riboflavin supplementation (86%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>Whereas late-onset RTD may mimic different acquired or genetic causes of motor neuropathies, it is a diagnosis not to be missed since high-dose riboflavin per oral supplementation is often highly efficient.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2020-323304","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T21:26:50Z","timestamp":1603315610000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies"],"prefix":"10.1136","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7000-9367","authenticated-orcid":false,"given":"Christophe","family":"Carreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Cauquil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-4857","authenticated-orcid":false,"given":"Agathe","family":"Roubertie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Veauville-Merlli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Acquaviva-Bourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-6957","authenticated-orcid":false,"given":"Yann","family":"Nadjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"2021022403000736000_92.1.27.1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00005053-189411000-00003","article-title":"Infantile amyotrophic lateral sclerosis of the family type","volume":"21","author":"Brown","year":"1894","journal-title":"J Nerv Ment Dis"},{"key":"2021022403000736000_92.1.27.2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1017\/S0022215114003375","article-title":"Auditory neuropathy spectrum disorder with Brown\u2013Vialetto\u2013Van Laere syndrome: challenges in hearing rehabilitation","volume":"129","author":"Chandran","year":"2015","journal-title":"J Laryngol Otol"},{"key":"2021022403000736000_92.1.27.3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54","volume":"86","author":"Green","year":"2010","journal-title":"Am J Hum Genet"},{"key":"2021022403000736000_92.1.27.4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.abb.2013.02.015","article-title":"The human flavoproteome","volume":"535","author":"Lienhart","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"2021022403000736000_92.1.27.5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/ajcn\/77.6.1352","article-title":"Riboflavin (vitamin B-2) and health","volume":"77","author":"Powers","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"2021022403000736000_92.1.27.6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.mam.2012.07.014","article-title":"Novel riboflavin transporter family RFVT\/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT\/SLC52","volume":"34","author":"Yonezawa","year":"2013","journal-title":"Mol Aspects Med"},{"key":"2021022403000736000_92.1.27.7","doi-asserted-by":"crossref","unstructured":"Bosch AM , Stroek K , Abeling NG , et al . The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis 2012;7:83. doi:10.1186\/1750-1172-7-83","DOI":"10.1186\/1750-1172-7-83"},{"key":"2021022403000736000_92.1.27.8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"2021022403000736000_92.1.27.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2014.10.016","article-title":"Adult onset Brown\u2013Vialetto\u2013Van Laere syndrome with opsoclonus and a novel heterozygous mutation: a case report","volume":"128","author":"Cosgrove","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"2021022403000736000_92.1.27.10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mus.24224","article-title":"Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood","volume":"50","author":"Srour","year":"2014","journal-title":"Muscle Nerve"},{"key":"2021022403000736000_92.1.27.11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajhg.2010.05.021","article-title":"Exome sequencing in Brown-Vialetto-van Laere syndrome","volume":"87","author":"Johnson","year":"2010","journal-title":"Am J Hum Genet"},{"key":"2021022403000736000_92.1.27.12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genetics in Medicine"},{"key":"2021022403000736000_92.1.27.13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/practneurol-2016-001488","article-title":"Remarkable motor recovery after riboflavin therapy in adult-onset Brown\u2014Vialetto\u2014Van Laere syndrome","volume":"17","author":"Bashford","year":"2017","journal-title":"Pract Neurol"},{"key":"2021022403000736000_92.1.27.14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.nmd.2012.05.007","article-title":"Brown\u2013Vialetto\u2013van Laere and Fazio\u2013Londe overlap syndromes: a clinical, biochemical and genetic study","volume":"22","author":"Ciccolella","year":"2012","journal-title":"Neuromuscular Disorders"},{"key":"2021022403000736000_92.1.27.15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/jhg.2012.70","article-title":"Four novel C20orf54 mutations identified in Brown\u2013Vialetto\u2013Van Laere syndrome patients","volume":"57","author":"Dezfouli","year":"2012","journal-title":"J Hum Genet"},{"key":"2021022403000736000_92.1.27.16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/21678421.2013.837931","article-title":"Brown-Vialetto-Van Laere syndrome: clinical and neuroradiological findings of a genetically proven patient","volume":"15","author":"Bandettini Di Poggio","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2021022403000736000_92.1.27.17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2014-310088","article-title":"Brown-Vialetto-Van Laere syndrome: a 28-year follow-up","volume":"87","author":"Davis","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021022403000736000_92.1.27.18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0883073816689517","article-title":"Brown-Vialetto-Van Laere syndrome as a mimic of neuroimmune disorders: 3 cases from the clinic and review of the literature","volume":"32","author":"Allison","year":"2017","journal-title":"J Child Neurol"},{"key":"2021022403000736000_92.1.27.19","doi-asserted-by":"crossref","unstructured":"Camargos S , Guerreiro R , Bras J , et al . Late-Onset and acute presentation of Brown-Vialetto-Van Laere syndrome in a Brazilian family. Neurol Genet 2018;4:e215. doi:10.1212\/NXG.0000000000000215","DOI":"10.1212\/NXG.0000000000000215"},{"key":"2021022403000736000_92.1.27.20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/acn3.50977","article-title":"A juvenile ALS\u2010like phenotype dramatically improved after high\u2010dose riboflavin treatment","volume":"7","author":"Carreau","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2021022403000736000_92.1.27.21","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan B , Bosch AM , Houlden H . An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency. J Inherit Metab Dis 2020.","DOI":"10.1002\/jimd.12053"},{"key":"2021022403000736000_92.1.27.22","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/brain\/awx231","article-title":"Clinical, pathological and functional characterization of riboflavin-responsive neuropathy","volume":"140","author":"Manole","year":"2017","journal-title":"Brain"},{"key":"2021022403000736000_92.1.27.23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10545-016-9924-2","article-title":"Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience","volume":"39","author":"Jaeger","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"2021022403000736000_92.1.27.24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2017.03.001","article-title":"Genetic, radiologic, and clinical variability in Brown-Vialetto-van Laere syndrome","volume":"26","author":"Woodcock","year":"2018","journal-title":"Semin Pediatr Neurol"},{"key":"2021022403000736000_92.1.27.25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF00314095","article-title":"Juvenile-Onset bulbospinal muscular atrophy with deafness: Vialetta-van laere syndrome or madras-type motor neuron disease?","volume":"234","author":"Summers","year":"1987","journal-title":"J Neurol"},{"key":"2021022403000736000_92.1.27.26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jmg.27.3.176","article-title":"Pontobulbar palsy and neurosensory deafness (Brown-Vialetto-Van Laere syndrome) with possible autosomal dominant inheritance","volume":"27","author":"Hawkins","year":"1990","journal-title":"J Med Genet"},{"key":"2021022403000736000_92.1.27.27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nmd.2005.05.003","article-title":"Clinical features and neurophysiological follow-up in a case of Brown-Vialetto-Van Laere syndrome","volume":"15","author":"De Grandis","year":"2005","journal-title":"Neuromuscular Disorders"},{"key":"2021022403000736000_92.1.27.28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"2021022403000736000_92.1.27.29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp-2014-308946","article-title":"The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey","volume":"86","author":"Turner","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021022403000736000_92.1.27.30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2018.05.005","article-title":"Dramatic improvement of a rare syndrome with high dose riboflavin treatment","volume":"86","author":"Forman","year":"2018","journal-title":"Pediatr Neurol"},{"key":"2021022403000736000_92.1.27.31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.spen.2017.03.002","article-title":"The first case of riboflavin transporter deficiency in sub-Saharan Africa","volume":"26","author":"Chaya","year":"2018","journal-title":"Semin Pediatr Neurol"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-323304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:10:01Z","timestamp":1614165001000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-323304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12,15]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/jnnp-2020-323304"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-323304","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}